Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

TG Therapeutics Company Profile (NASDAQ:TGTX)

Consensus Ratings for TG Therapeutics (NASDAQ:TGTX) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.25 (95.65% upside)

Analysts' Ratings History for TG Therapeutics (NASDAQ:TGTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/25/2014Brean CapitalBoost Price TargetBuy$19.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2014MLV & Co Reiterated RatingBuy -> Positive$16.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2014Brean CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
7/22/2014Roth CapitalBoost Price TargetBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2014Brean CapitalBoost Price TargetBuy$13.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2014MLV & Co Boost Price TargetBuy$10.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
6/16/2014Ladenburg ThalmannSet Price Target$12.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014Roth CapitalReiterated RatingFocus ListViewTweet This Rating  Share This Rating on StockTwits
4/4/2014Brean CapitalInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
3/7/2014MLV & Co Boost Price TargetBuy$9.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
11/25/2013Ladenburg ThalmannBoost Price TargetBuy$8.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2013MLV & Co Initiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
10/4/2013Ladenburg ThalmannReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Ladenburg ThalmannReiterated RatingBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2013Ladenburg ThalmannBoost Price TargetBuy$6.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
3/13/2013Roth CapitalInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
12/7/2012Ladenburg ThalmannInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/2/2012 forward)
Discuss TG Therapeutics